{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:19:26Z","timestamp":1762157966111,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.126264","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:54:12Z","timestamp":1725522852000},"page":"126264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preferences of US adolescents and parents for vaccination against invasive meningococcal disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Katharina","family":"Schley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Whichello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Krucien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Peyrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Vespa","family":"Presa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2023","series-title":"European Centre for Disease Prevention and Control. Meningococcal disease","key":"10.1016\/j.vaccine.2024.126264_bb0005"},{"key":"10.1016\/j.vaccine.2024.126264_bb0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40121-022-00609-9","article-title":"Rationale for the development of a pentavalent meningococcal vaccine: a US-focused review","volume":"11","author":"Marshall","year":"2022","journal-title":"Infect Dis Ther"},{"year":"2022","series-title":"Centers for Disease Control and Prevention. Meningococcal Disease: Causes and How it Spreads","key":"10.1016\/j.vaccine.2024.126264_bb0015"},{"year":"2022","series-title":"Centers for Disease Control and Prevention","key":"10.1016\/j.vaccine.2024.126264_bb0020"},{"key":"10.1016\/j.vaccine.2024.126264_bb0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamapediatrics.2020.1990","article-title":"Incidence of meningococcal disease before and after implementation of quadrivalent meningococcal conjugate vaccine in the United States","volume":"174","author":"Mbaeyi","year":"2020","journal-title":"JAMA Pediatr"},{"year":"2023","series-title":"Centers for Disease Control and Prevention. Child and Adolescent Immunization Schedule by Age","key":"10.1016\/j.vaccine.2024.126264_bb0030"},{"key":"10.1016\/j.vaccine.2024.126264_bb0035","doi-asserted-by":"crossref","unstructured":"Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, et al. Vaccination coverage among adolescents aged 13\u201317 Years \u2014 National Immunization Survey\u2013Teen, United States, 2022. Morb Mortal Wkly Rep 2023;72:912\u20139.","DOI":"10.15585\/mmwr.mm7234a3"},{"key":"10.1016\/j.vaccine.2024.126264_bb0040","article-title":"A systematic review on COVID-19 vaccine preferences using discrete choice experiments (preprint)","author":"Amani","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.vaccine.2024.126264_bb0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40271-017-0244-x","article-title":"Individual preferences for child and adolescent vaccine attributes: a systematic review of the stated preference literature","volume":"10","author":"Michaels-Igbokwe","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.vaccine.2024.126264_bb0050","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1016\/j.vaccine.2020.08.078","article-title":"Parent, provider and vaccinee preferences for HPV vaccination: a systematic review of discrete choice experiments","volume":"38","author":"Lack","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126264_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1258\/135581907779497602","article-title":"Developing attributes and levels for discrete choice experiments using qualitative methods","volume":"12","author":"Coast","year":"2007","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.vaccine.2024.126264_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/heapol\/czn047","article-title":"How to do (or not to do) \u2026 Designing a discrete choice experiment for application in a low-income country","volume":"24","author":"Mangham","year":"2009","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2024.126264_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","article-title":"Discrete choice experiments in health economics: past, present and future","volume":"37","author":"Soekhai","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2024.126264_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40271-019-00401-x","article-title":"Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and reviewers","volume":"13","author":"Hollin","year":"2020","journal-title":"Patient"},{"year":"2024","series-title":"From qualitative research to quantitative preference elicitation: An example in invasive meningococcal disease","author":"Coulter","key":"10.1016\/j.vaccine.2024.126264_bb0075"},{"year":"2021","series-title":"Package leaflet: TRUMENBA","author":"Food and Drug Administration","key":"10.1016\/j.vaccine.2024.126264_bb0080"},{"key":"10.1016\/j.vaccine.2024.126264_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.conctc.2018.01.002","article-title":"Investigating the impact of design characteristics on statistical efficiency within discrete choice experiments: a systematic survey","volume":"10","author":"Vanniyasingam","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.vaccine.2024.126264_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jebo.2017.01.018","article-title":"Visual attention in multi-attributes choices: what can eye-tracking tell us?","volume":"135","author":"Krucien","year":"2017","journal-title":"J Econ Behav Organ"},{"key":"10.1016\/j.vaccine.2024.126264_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jval.2018.07.876","article-title":"The internal validity of discrete choice experiment data: a testing tool for quantitative assessments","volume":"22","author":"Johnson","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2024.126264_bb0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1467-8276.2005.00794.x","article-title":"Serial nonparticipation in repeated discrete choice models","volume":"87","author":"von Haefen","year":"2005","journal-title":"Am J Agric Econ"},{"key":"10.1016\/j.vaccine.2024.126264_bb0105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.vaccine.2017.12.043","article-title":"The vaccine hesitancy scale: psychometric properties and validation","volume":"36","author":"Shapiro","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126264_bb0110","first-page":"588","article-title":"Brief questions to identify patients with inadequate health literacy","volume":"36","author":"Chew","year":"2004","journal-title":"Fam Med"},{"key":"10.1016\/j.vaccine.2024.126264_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0272989X0102100105","article-title":"General performance on a numeracy scale among highly educated samples","volume":"21","author":"Lipkus","year":"2001","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.vaccine.2024.126264_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00133443","article-title":"The structure of random utility models","volume":"8","author":"Manski","year":"1977","journal-title":"Theor Decis"},{"year":"1959","series-title":"Binary choice constraints on random utility indicators. Cowles Foundation for Research in economics","author":"Marschak","key":"10.1016\/j.vaccine.2024.126264_bb0125"},{"year":"1974","series-title":"Conditional logit analysis of qualitative choice behaviour","author":"McFadden","key":"10.1016\/j.vaccine.2024.126264_bb0130"},{"key":"10.1016\/j.vaccine.2024.126264_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1037\/h0070288","article-title":"A law of comparative judgment","volume":"34","author":"Thurstone","year":"1927","journal-title":"Psychol Rev"},{"key":"10.1016\/j.vaccine.2024.126264_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40271-022-00610-x","article-title":"Patients\u2019 preferences for connected insulin pens: a discrete choice experiment among patients with type 1 and type 2 diabetes","volume":"16","author":"Seo","year":"2023","journal-title":"The Patient - Patient-Centered Outcomes Research"},{"key":"10.1016\/j.vaccine.2024.126264_bb0145","first-page":"32","article-title":"Apollo: a flexible, powerful and customisable freeware package for choice model estimation and application","author":"Hess","year":"2019","journal-title":"J Choice Model"},{"key":"10.1016\/j.vaccine.2024.126264_bb0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.vaccine.2015.11.075","article-title":"Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment","volume":"34","author":"Marshall","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126264_bb0155","first-page":"11","article-title":"The impact of social determinants of health on meningococcal vaccination awareness, delivery, and coverage in adolescents and young adults in the United States: a systematic review","author":"Masaquel","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126264_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40121-022-00708-7","article-title":"Societal preferences for meningococcal B vaccination in children: a discrete choice experiment in Spain","volume":"12","author":"Martinon-Torres","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.126264_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1468-0009.2009.00564.x","article-title":"Health consequences of uninsurance among adults in the United States: recent evidence and implications","volume":"87","author":"McWilliams","year":"2009","journal-title":"Milbank Q"},{"key":"10.1016\/j.vaccine.2024.126264_bb0170","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2179840","article-title":"Pandemic\u2019s influence on parents\u2019 attitudes and behaviors toward meningococcal vaccination","volume":"19","author":"Tan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.126264_bb0175","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","article-title":"How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity","volume":"19","author":"Quaife","year":"2018","journal-title":"Eur J Health Econ"},{"year":"2022","series-title":"Meningococcal Disease: Clinical Information","author":"CDC","key":"10.1016\/j.vaccine.2024.126264_bb0180"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T13:26:03Z","timestamp":1726233963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24009460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24009460"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126264","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferences of US adolescents and parents for vaccination against invasive meningococcal disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126264"}}